| GeneWeave Biosciences Attracts $12 Million in Venture Capital in Round Financed by Decheng Capital, Claremont Creek Ventures and X/Seed Capital
Capital Will Be Used to Complete the Development and Commercialization of the Company's First Molecular Diagnostic Product
|